Form 8-K - Current report:
SEC Accession No. 0000885590-22-000022
Filing Date
2022-05-10
Accepted
2022-05-10 07:04:56
Documents
14
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhc-20220510.htm   iXBRL 8-K 39077
2 EX-99.1 ex991-q1x2022.htm EX-99.1 477663
6 image2a.jpg GRAPHIC 7860
  Complete submission text file 0000885590-22-000022.txt   710061

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20220510.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20220510_lab.xml EX-101.LAB 25096
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20220510_pre.xml EX-101.PRE 13047
8 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20220510_htm.xml XML 11466
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 22907306
SIC: 2834 Pharmaceutical Preparations